In this podcast, experts discuss what people with early-stage lung cancer should know about molecular testing, including what it is, how it may be used in guiding treatment decisions, and several recent studies about its role in treatment planning.
Read research from the April 2022 session of the ASCO Plenary Series, which highlights a clinical trial that studied a medication called tislelizumab combined with chemotherapy to treat recurrent or metastatic nasopharyngeal cancer.
Read research from the March 2022 session of the ASCO Plenary Series, which highlights an immunotherapy combination to treat advanced melanoma and adding immunotherapy to chemotherapy to treat advanced non-small cell lung cancer.
In this podcast, Dr. Christopher Flowers discusses research from the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition, including studies evaluating new treatments for diffuse large B-cell lymphoma and an overview of a session on improving equity in cancer clinical trials.
Research from ASCO’s 2022 Gastrointestinal Cancers Symposium will feature 2 abstracts that looked at using immunotherapy to treat advanced liver cancer and biliary tract cancer.
Research from the first ASCO Plenary Series presentation has arrived. Read more about studies on using immunotherapy to treat metastatic melanoma and how technology can be used to find and manage symptoms during cancer treatment.
In this podcast, Dr. Tian Zhang and Dr. Afreen Shariff discuss the side effects of a type of immunotherapy called an immune checkpoint inhibitor and how people receiving this type of treatment can best monitor themselves for side effects.
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting on brain tumors, esophageal cancer, and colorectal cancer.
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting in lung cancer, breast cancer, and sarcoma and describe what this research means for people with cancer.
Dr. Craig A. Portell discusses what CAR T-cell therapy is, how it works, what its common side effects are, and how it’s changing the landscape of how some types of cancers are treated.
